Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005654 | nucleoplasm | 2 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 2 |
Related structures:
AlphaFold database: Q4QD37
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 124 | 126 | PF00675 | 0.557 |
CLV_NRD_NRD_1 | 96 | 98 | PF00675 | 0.383 |
CLV_PCSK_FUR_1 | 94 | 98 | PF00082 | 0.380 |
CLV_PCSK_KEX2_1 | 108 | 110 | PF00082 | 0.407 |
CLV_PCSK_KEX2_1 | 122 | 124 | PF00082 | 0.519 |
CLV_PCSK_KEX2_1 | 22 | 24 | PF00082 | 0.414 |
CLV_PCSK_KEX2_1 | 96 | 98 | PF00082 | 0.383 |
CLV_PCSK_PC1ET2_1 | 108 | 110 | PF00082 | 0.432 |
CLV_PCSK_PC1ET2_1 | 122 | 124 | PF00082 | 0.501 |
CLV_PCSK_PC1ET2_1 | 22 | 24 | PF00082 | 0.427 |
CLV_PCSK_PC7_1 | 104 | 110 | PF00082 | 0.445 |
CLV_PCSK_SKI1_1 | 108 | 112 | PF00082 | 0.557 |
CLV_PCSK_SKI1_1 | 138 | 142 | PF00082 | 0.383 |
CLV_PCSK_SKI1_1 | 19 | 23 | PF00082 | 0.463 |
DEG_APCC_DBOX_1 | 4 | 12 | PF00400 | 0.585 |
DOC_CYCLIN_RxL_1 | 104 | 112 | PF00134 | 0.526 |
DOC_CYCLIN_RxL_1 | 135 | 143 | PF00134 | 0.440 |
DOC_MAPK_gen_1 | 94 | 103 | PF00069 | 0.381 |
DOC_MAPK_MEF2A_6 | 147 | 154 | PF00069 | 0.393 |
DOC_USP7_MATH_1 | 118 | 122 | PF00917 | 0.725 |
DOC_USP7_MATH_1 | 38 | 42 | PF00917 | 0.539 |
DOC_WW_Pin1_4 | 191 | 196 | PF00397 | 0.489 |
DOC_WW_Pin1_4 | 3 | 8 | PF00397 | 0.528 |
LIG_14-3-3_CanoR_1 | 129 | 134 | PF00244 | 0.610 |
LIG_14-3-3_CanoR_1 | 138 | 143 | PF00244 | 0.413 |
LIG_14-3-3_CanoR_1 | 147 | 153 | PF00244 | 0.409 |
LIG_Actin_WH2_2 | 4 | 21 | PF00022 | 0.350 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.642 |
LIG_BRCT_BRCA1_1 | 86 | 90 | PF00533 | 0.480 |
LIG_FHA_1 | 170 | 176 | PF00498 | 0.412 |
LIG_FHA_1 | 180 | 186 | PF00498 | 0.390 |
LIG_FHA_1 | 195 | 201 | PF00498 | 0.371 |
LIG_FHA_1 | 73 | 79 | PF00498 | 0.437 |
LIG_FHA_2 | 128 | 134 | PF00498 | 0.508 |
LIG_FHA_2 | 43 | 49 | PF00498 | 0.475 |
LIG_FHA_2 | 50 | 56 | PF00498 | 0.463 |
LIG_LIR_Gen_1 | 133 | 144 | PF02991 | 0.473 |
LIG_LIR_Gen_1 | 157 | 167 | PF02991 | 0.475 |
LIG_LIR_Gen_1 | 45 | 51 | PF02991 | 0.455 |
LIG_LIR_Nem_3 | 133 | 139 | PF02991 | 0.498 |
LIG_LIR_Nem_3 | 157 | 162 | PF02991 | 0.468 |
LIG_LIR_Nem_3 | 197 | 202 | PF02991 | 0.463 |
LIG_LIR_Nem_3 | 45 | 50 | PF02991 | 0.448 |
LIG_NRBOX | 141 | 147 | PF00104 | 0.417 |
LIG_NRBOX | 87 | 93 | PF00104 | 0.486 |
LIG_SH2_CRK | 136 | 140 | PF00017 | 0.471 |
LIG_SH2_CRK | 159 | 163 | PF00017 | 0.414 |
LIG_SH2_NCK_1 | 170 | 174 | PF00017 | 0.472 |
LIG_SH2_PTP2 | 149 | 152 | PF00017 | 0.444 |
LIG_SH2_PTP2 | 199 | 202 | PF00017 | 0.389 |
LIG_SH2_STAP1 | 136 | 140 | PF00017 | 0.468 |
LIG_SH2_STAT5 | 144 | 147 | PF00017 | 0.283 |
LIG_SH2_STAT5 | 149 | 152 | PF00017 | 0.311 |
LIG_SH2_STAT5 | 199 | 202 | PF00017 | 0.389 |
LIG_SH3_3 | 147 | 153 | PF00018 | 0.385 |
LIG_SH3_3 | 31 | 37 | PF00018 | 0.412 |
LIG_SH3_3 | 8 | 14 | PF00018 | 0.498 |
LIG_SUMO_SIM_par_1 | 138 | 143 | PF11976 | 0.409 |
MOD_CK1_1 | 169 | 175 | PF00069 | 0.469 |
MOD_CK1_1 | 194 | 200 | PF00069 | 0.529 |
MOD_CK1_1 | 3 | 9 | PF00069 | 0.602 |
MOD_CK1_1 | 42 | 48 | PF00069 | 0.503 |
MOD_CK2_1 | 127 | 133 | PF00069 | 0.483 |
MOD_GlcNHglycan | 163 | 166 | PF01048 | 0.523 |
MOD_GlcNHglycan | 186 | 189 | PF01048 | 0.394 |
MOD_GlcNHglycan | 41 | 44 | PF01048 | 0.560 |
MOD_GlcNHglycan | 63 | 66 | PF01048 | 0.456 |
MOD_GSK3_1 | 109 | 116 | PF00069 | 0.570 |
MOD_GSK3_1 | 13 | 20 | PF00069 | 0.488 |
MOD_GSK3_1 | 38 | 45 | PF00069 | 0.479 |
MOD_GSK3_1 | 68 | 75 | PF00069 | 0.436 |
MOD_GSK3_1 | 82 | 89 | PF00069 | 0.408 |
MOD_N-GLC_1 | 179 | 184 | PF02516 | 0.431 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.652 |
MOD_NEK2_1 | 148 | 153 | PF00069 | 0.390 |
MOD_NEK2_1 | 17 | 22 | PF00069 | 0.467 |
MOD_NEK2_1 | 49 | 54 | PF00069 | 0.486 |
MOD_NEK2_1 | 61 | 66 | PF00069 | 0.529 |
MOD_NEK2_1 | 82 | 87 | PF00069 | 0.390 |
MOD_PKA_2 | 32 | 38 | PF00069 | 0.435 |
MOD_Plk_1 | 179 | 185 | PF00069 | 0.377 |
MOD_Plk_4 | 13 | 19 | PF00069 | 0.521 |
MOD_Plk_4 | 42 | 48 | PF00069 | 0.493 |
MOD_Plk_4 | 86 | 92 | PF00069 | 0.432 |
MOD_ProDKin_1 | 191 | 197 | PF00069 | 0.498 |
MOD_ProDKin_1 | 3 | 9 | PF00069 | 0.526 |
TRG_DiLeu_BaLyEn_6 | 106 | 111 | PF01217 | 0.522 |
TRG_ENDOCYTIC_2 | 136 | 139 | PF00928 | 0.470 |
TRG_ENDOCYTIC_2 | 149 | 152 | PF00928 | 0.390 |
TRG_ENDOCYTIC_2 | 159 | 162 | PF00928 | 0.377 |
TRG_ENDOCYTIC_2 | 199 | 202 | PF00928 | 0.389 |
TRG_ENDOCYTIC_2 | 47 | 50 | PF00928 | 0.459 |
TRG_ER_diArg_1 | 123 | 125 | PF00400 | 0.592 |
TRG_ER_diArg_1 | 96 | 98 | PF00400 | 0.379 |
TRG_NES_CRM1_1 | 143 | 157 | PF08389 | 0.388 |
TRG_NLS_Bipartite_1 | 108 | 126 | PF00514 | 0.616 |
TRG_NLS_MonoCore_2 | 121 | 126 | PF00514 | 0.557 |
TRG_NLS_MonoExtC_3 | 121 | 127 | PF00514 | 0.538 |
TRG_Pf-PMV_PEXEL_1 | 124 | 128 | PF00026 | 0.674 |
TRG_Pf-PMV_PEXEL_1 | 138 | 143 | PF00026 | 0.428 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1HX14 | Leptomonas seymouri | 76% | 100% |
A0A0S4IPP5 | Bodo saltans | 25% | 99% |
A0A1X0NWK9 | Trypanosomatidae | 35% | 100% |
A0A3R7K4I3 | Trypanosoma rangeli | 36% | 100% |
A0A3S5H778 | Leishmania donovani | 95% | 100% |
A4HBH6 | Leishmania braziliensis | 88% | 100% |
A4HYK0 | Leishmania infantum | 95% | 100% |
C9ZHU5 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 36% | 100% |
E9AUE7 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 95% | 100% |